Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study - PubMed (original) (raw)

Comment

Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study

Jia Ma et al. J Infect. 2020 Aug.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest All the authors have no conflicts of interest to declare.

Comment in

• Cancer in intensive care unit patients with COVID-19.
  Moiseev S, Avdeev S, Brovko M, Akulkina L, Fomin V. Moiseev S, et al. J Infect. 2020 Aug;81(2):e124-e125. doi: 10.1016/j.jinf.2020.05.053. Epub 2020 May 28. J Infect. 2020. PMID: 32474041 Free PMC article. No abstract available.
• Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis.
  Afshar ZM, Dayani M, Naderi M, Ghanbarveisi F, Shiri S, Rajati F. Afshar ZM, et al. J Infect. 2020 Aug;81(2):e114-e116. doi: 10.1016/j.jinf.2020.05.062. Epub 2020 May 28. J Infect. 2020. PMID: 32474042 Free PMC article. No abstract available.

Comment on

• Clinical progression of patients with COVID-19 in Shanghai, China.
  Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, Li F, Xu Q, Zhang Y, Xu S, Song Z, Zeng Y, Shen Y, Shi Y, Zhu T, Lu H. Chen J, et al. J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19. J Infect. 2020. PMID: 32171869 Free PMC article.

Similar articles

• Poor clinical outcomes for patients with cancer during the COVID-19 pandemic.
  Tang LV, Hu Y. Tang LV, et al. Lancet Oncol. 2020 Jul;21(7):862-864. doi: 10.1016/S1470-2045(20)30311-9. Epub 2020 May 29. Lancet Oncol. 2020. PMID: 32479788 Free PMC article. No abstract available.
• Cancer in intensive care unit patients with COVID-19.
  Moiseev S, Avdeev S, Brovko M, Akulkina L, Fomin V. Moiseev S, et al. J Infect. 2020 Aug;81(2):e124-e125. doi: 10.1016/j.jinf.2020.05.053. Epub 2020 May 28. J Infect. 2020. PMID: 32474041 Free PMC article. No abstract available.
• Risk factors for in-hospital mortality in patients with cancer and COVID-19.
  Zhang G, An Y, Zhang L, Xie L, Guo X. Zhang G, et al. Lancet Oncol. 2020 Sep;21(9):e407. doi: 10.1016/S1470-2045(20)30390-9. Lancet Oncol. 2020. PMID: 32888457 Free PMC article. No abstract available.
• Risk factors for in-hospital mortality in patients with cancer and COVID-19.
  Guo K, Sun L, Yuan L, Wasan HS, Ruan S. Guo K, et al. Lancet Oncol. 2020 Sep;21(9):e406. doi: 10.1016/S1470-2045(20)30426-5. Lancet Oncol. 2020. PMID: 32888456 Free PMC article. No abstract available.
• COVID-19: An Australian center's perspective.
  Lim L, Matalanis G. Lim L, et al. J Card Surg. 2021 May;36(5):1703-1706. doi: 10.1111/jocs.15129. Epub 2020 Oct 30. J Card Surg. 2021. PMID: 33124709 Review.

Cited by

• Coronavirus infection in cancer patients, last update.
  Borregón Rivilla M, Martínez Barroso KA. Borregón Rivilla M, et al. Med Clin (Engl Ed). 2020 Oct 9;155(7):299-301. doi: 10.1016/j.medcle.2020.05.021. Epub 2020 Sep 12. Med Clin (Engl Ed). 2020. PMID: 32953991 Free PMC article. No abstract available.
• Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients.
  Sun L, Surya S, Le AN, Desai H, Doucette A, Gabriel P, Ritchie M, Rader D, Maillard I, Bange E, Huang A, Vonderheide RH, DeMichele A, Verma A, Mamtani R, Maxwell KN. Sun L, et al. medRxiv [Preprint]. 2020 Aug 15:2020.08.14.20174961. doi: 10.1101/2020.08.14.20174961. medRxiv. 2020. PMID: 32817956 Free PMC article. Updated. Preprint.
• Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
  Wang B, Fu J, Lu A, Yang J. Wang B, et al. J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.030. Epub 2022 May 31. J Infect. 2022. PMID: 35659914 Free PMC article. No abstract available.
• Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients.
  Moghimi M, Jozpanahi M, Khodadadi K, Saeed SP, Pirsaraie SVA, Jalili N. Moghimi M, et al. Eur J Transl Myol. 2022 Jun 20;32(2):10582. doi: 10.4081/ejtm.2022.10582. Eur J Transl Myol. 2022. PMID: 35723624 Free PMC article.
• Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.
  Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Bao J, et al. Clin Chim Acta. 2020 Oct;509:180-194. doi: 10.1016/j.cca.2020.06.009. Epub 2020 Jun 6. Clin Chim Acta. 2020. PMID: 32511971 Free PMC article.

References

1. 1. Chen Jun, Qi Tangkai, Liu Li. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 - PMC - PubMed
2. 1. Liang Wenhua, Guan Weijie, Chen Ruchong. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 - PMC - PubMed
3. 1. Yu Jing, Ouyang Wen, Melvin L. K. chua, et al. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020 - PMC - PubMed
4. 1. Zhang L., Zhu F., Xie L. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 - PMC - PubMed
5. 1. National Health Commission of China . (7th ed.) 2020. New coronavirus pneumonia prevention and control program.http://www.gov.cn/zhengce/zhengceku/2020-03/04/5486705/files/ae61004f930... Mar 3. (in Chinese)

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central